Features

Legal Operations Chiefs Say Managing Technology and Cutting Costs Are Main Priorities, Not Blockchain or AI
In-house legal operations chiefs see their main priorities as managing legal technology and cost-cutting, primarily on outside counsel spending. Blockchain remains a confusing concept to them, while artificial intelligence is the hottest topic of conversation.
Features

'Dark Overlord' Hack Shows Mounting Cyber Risks for Law Firms
<b><i>The Hacker Group Wants Ransom Payments from Dozens of Firms Involved In the Sept. 11 Litigation, and Experts Warn That More Attacks Are Coming</b></i><p>Leaders of those law firms are all likely scratching their heads about how to handle a recent announcement from a nebulous hacker entity calling itself the “Dark Overlord,” which claims to be in possession of 18,000 legal and insurance documents pertaining to the court fight.
Features

Sales Speak: The Reason Companies Aren't Buying Is How Lawyers Are Selling
Conventional business development methods ignore an important part of the legal services selling process: the legal services buying process.
Features

Voice of the Client: So Important, It Comes First
It is vital to have effective marketing and communications, but if legal and business professionals don't listen for — and hear — the Voice of the Client, we risk missing the mark in our strategy, messaging and positioning.
Features

Digital Dive: How to Create (at least) Nine Pieces of Content in One Hour
In just one hour, would it be valuable to have at least nine pieces of content that your lawyer clients may use on your website and on social media?
Features

Planning for the Crisis That Will Strike Your Law Firm
Reputation is everything. It only takes one misstep to cause irreparable damage to a law firm and its attorneys. As we get into 2019, it is imperative for law firms to plan for the effective management of myriad incidents that may have an adverse impact on the business of law and the reputation of the firm.
Features

11th Circuit Weighs in on Intersection of Lanham Act and FDCA Protein Powder Labeling Requirements
A battle between two dietary supplement manufacturers has revived interested in the intersection between the Lanham Act and federal labeling regulations. The issue: can an advertiser challenge a competitor's product label for false advertising under the Lanham Act if it complies with applicable federal regulations?
Features

The USPTO Brings New Guidance to the Section 101 Quandary
<b><i>Part Two of a Two-Part Article</b></i><p>USPTO Attempts to Provide Greater Clarity for Patent-Eligible Subject Matter
Columns & Departments
IP News
Kapoor v. National Rifle Association of America
Features

First Department Construes Open Space Requirement
In Peyton v. New York City Board of Standards and Appeals, the First Department faced a difficult question: when a zoning lot includes more than one building, can open space accessible to residents of one building, but not to residents of the other buildings, count as open space within the meaning of the New York City Zoning Resolution?
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Protecting Innovation in the Cyber World from Patent TrollsWith trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.Read More ›
- Meet the Lawyer Working on Inclusion Rider LanguageAt the Oscars in March, Best Actress winner Frances McDormand made “inclusion rider” go viral. But Kalpana Kotagal, a partner at Cohen Milstein Sellers & Toll had already worked for months to write the language for such provisions. Kotagal was developing legal language for contract provisions that Hollywood's elite could use to require studios and other partners to employ diverse workers on set.Read More ›
- From the PTO to the FDA: What to Consider When Branding Clinical TrialsThe legal implications of branding generally arise initially for companies during the process of selecting a company name and any initial product or service names. For drug development companies, however, careful consideration should also be paid to the implications of branding a clinical trial.Read More ›
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›